Glucose Teva (Glucose)

Glucose Teva is employed in clinical settings where a direct source of glucose is needed for local tissue metabolism or procedural support.

• Provides an immediate carbohydrate substrate during epidural procedures.
• Serves as an energy source in intrabursal injections for joint interventions.
• Used as a glucose infusion in intracoronary applications during cardiac catheterisation.
• Supports metabolic needs of tissues exposed to ischemia in surgical contexts.
• May be utilised in research protocols requiring sterile glucose solutions.

Adverse reactions to Glucose Teva are generally related to the route of administration and the sterile solution itself.

Common

• Local pain or discomfort at the injection site.
• Mild erythema or bruising.
• Transient headache.
• Nausea or mild dizziness.
• Temporary increase in blood glucose levels.

Serious

• Infection at the administration site.
• Allergic or hypersensitivity reaction (rash, urticaria, anaphylaxis).
• Embolism or vascular occlusion.
• Severe hypotension or cardiovascular instability.
• Tissue necrosis or ulceration.

When using Glucose Teva, clinicians should observe standard aseptic technique and consider patient‑specific factors to minimise risk.

• Verify sterility and integrity of the container before use.
• Assess patient’s glucose tolerance and diabetic status.
• Use only the intended routes (epidural, intrabursal, intracoronary); other routes are not approved.
• Monitor vital signs and blood glucose during and after administration.
• Avoid administration in patients with known hypersensitivity to glucose solutions.
• Store according to manufacturer’s instructions to maintain solution stability.

Glucose solutions can interact with other agents administered intravenously or locally; awareness of potential interactions helps ensure safe use.

Avoid

• Co‑administration with hyperosmolar agents that may increase risk of local tissue injury.
• Simultaneous injection of particulate suspensions that could precipitate emboli.

Use with caution

• Concurrent use of insulin or other glucose‑lowering medications; monitor blood glucose closely.
• Combination with vasoconstrictors that may affect local circulation.
• Administration alongside contrast media in coronary procedures; observe for additive osmolar load.
• Use with other epidural drugs that may alter analgesic efficacy or cause additive side effects.